EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Mechanically Triggered DNA Nanovehicles for Targeted Dual‐Drug Cancer Therapy

Murali Mohana Rao Singuru iD, Priyanka Bhattacharyya, Mingxu You iD

Advanced Science · 2026

DOI: 10.1002/advs.75286 ↗

At a glance

Journal article in Advanced Science, 2026. Written by Murali Mohana Rao Singuru and 2 co-authors. Institution: Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts, USA. Major MEDLINE topics: Drug Delivery Systems, Doxorubicin, Antineoplastic Agents, DNA. Cited 1 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, National Science Foundation, Camille Dreyfus Teacher-Scholar Award.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Stimuli‐responsive dual‐drug delivery systems enable precise therapeutic control by co‐releasing multiple agents, enhancing synergy while reducing dosage and side effects. Mechanical dysregulation is a hallmark of various diseases, yet force‐responsive platforms remain rare. Here, we introduce a DNA‐based mechanical nanovehicle that releases two anticancer drugs—TMPyP4 and doxorubicin—in response to tensile forces generated by integrin receptors at cell–cell junctions. The cholesterol‐modified DNA constructs anchor to the cell membrane and undergoes force‐induced structural changes, triggering rapid drug release under defined mechanical conditions. Our studies demonstrated selective activation in HeLa and MCF‐7 cancer cells, achieving potent cytotoxicity while minimizing off‐target effects in low‐tension HEK293T cells. This modular platform integrates mechanosensing, real‐time force visualization, and targeted therapy, establishing a new class of mechanoresponsive dual‐drug delivery systems for safer and more effective cancer treatments.

Subjects

MeSH terms (MEDLINE)

Drug Delivery SystemsDoxorubicinAntineoplastic AgentsDNANeoplasmsHumansDNA NanostructuresHeLa CellsMCF-7 Cells

Author keywords

DNA nanovehicledual‐drug deliveryintegrin‐mediated forcesintercellular forcestargeted cancer therapy

Substances

DoxorubicinAntineoplastic AgentsDNA

Authors and institutions

  • Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts, USA.
  • Molecular and Cellular Biology Graduate Program, University of Massachusetts Amherst, Amherst, Massachusetts, USA.

ORCID profiles: Murali Mohana Rao Singuru, Mingxu You

Funding

  • NIGMS NIH HHS
  • National Science Foundation
  • Camille Dreyfus Teacher-Scholar Award
  • National Institute of General Medical Sciences

Cite

APA

Singuru, M. M. R., Bhattacharyya, P., & You, M. (2026). Mechanically Triggered DNA Nanovehicles for Targeted Dual‐Drug Cancer Therapy. Advanced Science. https://doi.org/10.1002/advs.75286

Vancouver

Singuru MMR, Bhattacharyya P, You M. Mechanically Triggered DNA Nanovehicles for Targeted Dual‐Drug Cancer Therapy. Advanced Science. 2026. doi:10.1002/advs.75286

BibTeX
@article{Singuru2026,
  author = {Singuru, Murali Mohana Rao and Bhattacharyya, Priyanka and You, Mingxu},
  title = {Mechanically Triggered DNA Nanovehicles for Targeted Dual‐Drug Cancer Therapy},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.75286}
}
Start for free →